Home/Filings/4/0001209191-23-058465
4//SEC Filing

Dinsmore Christopher 4

Accession 0001209191-23-058465

CIK 0001741830other

Filed

Dec 12, 7:00 PM ET

Accepted

Dec 13, 4:10 PM ET

Size

5.2 KB

Accession

0001209191-23-058465

Insider Transaction Report

Form 4
Period: 2023-12-12
Dinsmore Christopher
Chief Scientific Officer
Transactions
  • Sale

    Common Stock

    2023-12-12$1.30/sh10,032$13,092268,335 total
Footnotes (2)
  • [F1]Represents shares sold to satisfy estimated tax withholding obligations upon the settlement of restricted stock units.
  • [F2]The weighted average sale price for the transaction reported was $1.305, and the range of prices were between $1.215 to $1.41. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

Issuer

Kronos Bio, Inc.

CIK 0001741830

Entity typeother

Related Parties

1
  • filerCIK 0001826766

Filing Metadata

Form type
4
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 4:10 PM ET
Size
5.2 KB